Genomics and proteomics of retinopathy of prematurity: DNA-based prevention ana treatment

British Journal of Ophthalmology

Volumn 91, Issue 12, 2007, Pages 1577-

  Good, W V ^a,c   Gendron, R L ^b  

^a SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

BLINDNESS; DISEASE ASSOCIATION; EDITORIAL; GENE MUTATION; GENOMICS; GLAUCOMA; HUMAN; MYOPIA; NYSTAGMUS; PRIORITY JOURNAL; PROTEOMICS; RETROLENTAL FIBROPLASIA; RISK FACTOR; SCREENING; STRABISMUS; VISUAL ACUITY;

ANIMALS; DNA; GENOMICS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PROTEOMICS; RETINOPATHY OF PREMATURITY;

EID: 36749067923     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.124404     Document Type: Editorial

References (1)

1. Holmström G, van Wijngaarden P, Coster DJ, et al. Genetic susceptibility to retinopathy of prematurity - the evidence from clinical and experimental animal studies. Br J Ophthalmol 2007;91:1704-8.